Medpace (MEDP)
(Real Time Quote from BATS)
$397.93 USD
-2.28 (-0.57%)
Updated Apr 30, 2024 10:46 AM ET
1-Strong Buy of 5 1
D Value A Growth D Momentum C VGM
Medpace (MEDP) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$448.60 | $480.00 | $395.00 | 12.09% |
Price Target
Based on short-term price targets offered by five analysts, the average price target for Medpace comes to $448.60. The forecasts range from a low of $395.00 to a high of $480.00. The average price target represents an increase of 12.09% from the last closing price of $400.21.
Analyst Price Targets (5 )
Broker Rating
Medpace currently has an average brokerage recommendation (ABR) of 1.33 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by six brokerage firms. The current ABR compares to an ABR of 1.67 a month ago based on six recommendations.
Of the six recommendations deriving the current ABR, five are Strong Buy, representing 83.33% of all recommendations. A month ago, Strong Buy represented 66.67%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 5 | 5 | 4 | 4 | 3 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 1 | 1 | 2 | 1 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.33 | 1.33 | 1.67 | 1.40 | 1.80 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
4/24/2024 | Robert W. Baird & Co. | Eric W Coldwell | Strong Buy | Strong Buy |
4/24/2024 | Guggenheim Securities | Jack D Wallace | Strong Buy | Strong Buy |
4/23/2024 | William Blair | Maxwell A Smock | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.33 |
ABR (Last week) | 1.33 |
# of Recs in ABR | 6 |
Average Target Price | $448.60 |
LT Growth Rate | 17.90% |
Industry | Medical Services |
Industry Rank by ABR | 85 of 252 |
Current Quarter EPS Est: | 2.50 |